Eyal Barash founded Barash Law LLC in 2009 to be a “roving” in-house General and IP counsel to early and mid-stage start-ups primarily coming out of the Purdue Research Park in West Lafayette, Indiana. He advises or has advised more than 20 start-up companies from Purdue alone and taken them through multiple stages of development including in-licenses, out-licenses, public offerings, private sales and public exits. In 2018, one of Eyal’s clients, Endocyte, Inc. was sold to Novartis for over $2B. Eyal was chief patent counsel to Endocyte for almost 10 years. Eyal is also a prolific speaker and lecturer, giving presentations primarily in life science IP throughout the globe. He has a particular interest in drug repositioning and repurposing and lectures on this topic frequently. Eyal’s current clients have a global footprint and are in the pharmaceutical, medical device, energy, defense, and agriculture sectors.